Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance lapatinib versus placebo after first-line chemotherapy in HER1/HER2-overexpressing advanced or metastatic bladder cancer
2007-001826-28Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in bladder cancer and transitional cell carcinoma (TCC) comparing Lapatinib maintenance with Placebo maintenance (2 arms). Primary endpoint: Progression-free survival. Started Aug 2007; status: completed.
02
Drugs
lapatinib
03
Conditions
bladder cancertransitional cell carcinoma (TCC)
Beyond the preview
Go deeper on 2007-001826-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001826-28.